DocMorris AG (SWX:DOCM)
9.83
-0.13 (-1.26%)
Aug 24, 2026, 5:14 PM CET
DocMorris AG Revenue
DocMorris AG had revenue of 599.71M CHF in the half year ending June 30, 2026, with 20.46% growth. This brings the company's revenue in the last twelve months to 1.18B, up 9.46% year-over-year. In the year 2025, DocMorris AG had annual revenue of 1.13B with 9.33% growth.
Revenue (ttm)
1.18B
Revenue Growth
+9.46%
P/S Ratio
0.43
Revenue / Employee
884.20K
Employees
1,576
Market Cap
502.62M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13B | 96.42M | 9.33% |
| Dec 31, 2024 | 1.03B | 56.54M | 5.79% |
| Dec 31, 2023 | 976.37M | 22.90M | 2.40% |
| Dec 31, 2022 | 953.47M | -779.78M | -44.99% |
| Dec 31, 2021 | 1.73B | 241.52M | 16.19% |
| Dec 31, 2020 | 1.49B | 94.15M | 6.74% |
| Dec 31, 2019 | 1.40B | 187.40M | 15.49% |
| Dec 31, 2018 | 1.21B | 217.51M | 21.91% |
| Dec 31, 2017 | 992.66M | 107.73M | 12.17% |
| Dec 31, 2016 | 884.94M | 44.18M | 5.26% |
| Dec 31, 2015 | 840.75M | -80.10M | -8.70% |
| Dec 31, 2014 | 920.85M | 3.30M | 0.36% |
| Dec 31, 2013 | 917.55M | 374.14M | 68.85% |
| Dec 31, 2012 | 543.41M | 54.98M | 11.26% |
| Dec 31, 2011 | 488.43M | -1.25M | -0.26% |
| Dec 31, 2010 | 489.68M | -40.23M | -7.59% |
| Dec 31, 2009 | 529.90M | 8.96M | 1.72% |
| Dec 31, 2008 | 520.94M | 837.00K | 0.16% |
| Dec 31, 2007 | 520.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.96B |
| Novartis AG | 45.81B |
| Lonza Group AG | 6.87B |
| Galderma Group AG | 4.79B |
| Basilea Pharmaceutica AG | 247.42M |
| COLTENE Holding AG | 234.80M |
| Metall Zug AG | 194.62M |
| IVF Hartmann Holding AG | 161.85M |
DocMorris AG News
- 5 days ago - DocMorris AG Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - DocMorris AG Quarterly report: Q2 2026 - Filings
- 5 days ago - DocMorris AG Earnings release: Q2 2026 - Filings
- 5 days ago - DocMorris AG Slides: Q2 2026 - Filings
- 5 weeks ago - DocMorris upgraded to Neutral from Sell at UBS - TheFly
- 5 weeks ago - DocMorris AG Earnings release: Q2 2026 - Filings
- 6 weeks ago - DocMorris upgraded to Buy from Hold at Deutsche Bank - TheFly
- 4 months ago - DocMorris AG Earnings Call Transcript: Q1 2026 - Transcripts